Press "Enter" to skip to content

Trial Alleging Merck Hid Dangers of HPV Vaccine Delayed Again

After years of false starts, the trial got underway in January and was slated to run for six weeks. However, on Feb. 14, attorneys for Merck and the plaintiff agreed to reconvene the trial in September, with a new jury and new information.

By Brenda Baletti, Ph.D.

A landmark court case alleging Merck’s Gardasil human papillomavirus (HPV) vaccine seriously injured a 16-year-old girl was temporarily suspended late last week by mutual agreement of both parties, according to the plaintiff’s lawyer.

The lawsuit, filed in 2016, accuses Merck of fraud, negligence and concealing the likelihood and severity of adverse effects associated with its Gardasil HPV vaccine.

After years of false starts, the trial got underway in January and was slated to run for six weeks.

However, on Feb. 14, attorneys for Merck and the plaintiff agreed to reconvene the trial in September. The trial will start over from scratch — a new jury will be selected and the experts will testify again.

“Both sides believe that more information can better inform the trial,” lead plaintiff attorney Mark Lanier told The Defender. “The adjournment was initially our idea. We have some more developments in the near future, plus it was really tough having the trial while the confirmation hearings were ongoing.”

Read Full Article Here…(childrenshealthdefense.org)


Home | Caravan to Midnight (zutalk.com)

Live Stream + Chat (zutalk.com)

We Need Your Help to Keep Caravan To Midnight Going,

Please Consider Donating to Help Keep Independent Media Independent

Breaking News: